Richard Newitter

Q: What is Richard Newitter's success rate?

Richard Newitter currently has a success rate of 92.31347592353887.

Q: What is the average return of Richard Newitter's calls?

Their stock ratings have generated an average return of 14.187187889809428.

Truist Securities | Healthcare

Richard Newitter is an analyst from Truist Securities specializing in the Healthcare sector. Ranked #1519 out of 4779 analysts, they have issued 123 stock ratings with a success rate of 92.31% and an average return of 14.19%.

Richard Newitter has a well-established track record, with 123 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 92.31% and an average return of 14.19%, underscoring their expertise and ability to identify winning opportunities for investors.

#1519

Out of 4779

123

Total Ratings

+92.31%

Success Rate

+14.19%

Average Return

Recent Ratings Analysis

BBNX

Buy

Sep 15, 2026

Target

$23.00

Current

$21.89

Performance

13.83%

Richard Newitter rated BBNX as Buy on Sep 15, 2026, setting a price target of 23. The call has proven timely, with shares rising 13.83% toward the price target of 23.

MDT

Hold

Sep 02, 2026

Target

$99.00

Current

$92.13

Performance

-0.05%

On Sep 02, 2026, MDT was given a Hold rating by Richard Newitter, with a target price of 99. Market indecision, reflected in sideways trading near 92.13, supported the cautious call.

PODD

Hold

Aug 06, 2026

Target

$153.00

Current

$140.60

Performance

0.93%

PODD received a Hold rating from Richard Newitter on Aug 06, 2026, aiming for 153. Shares remained flat at 140.6, aligning with the neutral rating.

LNTH

Hold

Aug 04, 2026

Target

$102.50

Current

$100.55

Performance

-0.55%

On Aug 04, 2026, Richard Newitter published a Hold outlook on LNTH, with a target of 102.5. Sideways action left the Hold view intact, with no major move since 100.55.

INSP

Hold

Aug 04, 2026

Target

$62.00

Current

$76.78

Performance

19.71%

Richard Newitter on Aug 04, 2026 assigned INSP a Hold rating, with a price target of 62. Shares outperformed expectations, climbing 19.71% despite the neutral view.

SIBN

Buy

Aug 04, 2026

Target

$23.00

Current

$18.09

Performance

-1.90%

On Aug 04, 2026, Richard Newitter reaffirmed SIBN with a Buy rating, targeting 23. Market indecision has kept the 23 target in a holding pattern.

ITGR

Hold

Aug 04, 2026

Target

$127.00

Current

$126.28

Performance

0.98%

ITGR was rated Hold by Richard Newitter on Aug 04, 2026, with a price objective of 127. Flat performance suggests the Hold view was reasonable.

SYK

Hold

Jul 31, 2026

Target

$340.00

Current

$275.12

Performance

-15.53%

On Jul 31, 2026, Richard Newitter initiated coverage on SYK with a Hold rating and target of 340. The rating matched the stock’s inability to hold above 275.12.

VCEL

Buy

Jul 31, 2026

Target

$58.00

Current

$40.02

Performance

-12.92%

Richard Newitter issued a Buy recommendation for VCEL on Jul 31, 2026, price target set at 58. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

DXCM

Buy

Jul 31, 2026

Target

$93.00

Current

$89.35

Performance

7.07%

On Jul 31, 2026, DXCM was evaluated by Richard Newitter, who gave a Buy rating and target of 93. This case illustrates how a timely bullish rating can translate into tangible gains of 7.07%.

GKOS

Buy

Jul 30, 2026

Target

$215.00

Current

$163.81

Performance

-2.79%

Richard Newitter rated GKOS as Buy on Jul 30, 2026, setting a price target of 215. Shares have remained stable near 163.81, leaving the 215 target still in play.

BSX

Buy

Jul 30, 2026

Target

$57.00

Current

$43.34

Performance

-5.78%

On Jul 30, 2026, BSX was given a Buy rating by Richard Newitter, with a target price of 57. Despite the Buy call, shares fell from 43.34 to 43.34, challenging the optimistic stance.

KIDS

Hold

Jul 16, 2026

Target

$20.00

Current

$21.82

Performance

7.07%

KIDS received a Hold rating from Richard Newitter on Jul 16, 2026, aiming for 20. Investors saw gains of 7.07% that the cautious stance didn’t fully capture.

EW

Hold

Jul 16, 2026

Target

$95.00

Current

$88.26

Performance

0.48%

On Jul 16, 2026, Richard Newitter published a Hold outlook on EW, with a target of 95. Sideways action left the Hold view intact, with no major move since 88.26.

GMED

Buy

Jul 16, 2026

Target

$100.00

Current

$74.08

Performance

-8.44%

Richard Newitter on Jul 16, 2026 assigned GMED a Buy rating, with a price target of 100. The call has struggled to gain traction, with shares losing 8.44%.

IRTC

Buy

Jul 16, 2026

Target

$160.00

Current

$109.33

Performance

-5.22%

On Jul 16, 2026, Richard Newitter reaffirmed IRTC with a Buy rating, targeting 160. Shares slid 5.22% despite the recommendation, highlighting downside risks.

ISRG

Buy

Jul 16, 2026

Target

$510.00

Current

$393.33

Performance

-2.24%

ISRG was rated Buy by Richard Newitter on Jul 16, 2026, with a price objective of 510. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

TMCI

Hold

Jul 16, 2026

Target

$4.00

Current

$4.49

Performance

1.35%

On Jul 16, 2026, Richard Newitter initiated coverage on TMCI with a Hold rating and target of 4. The stock’s lack of movement around 4.49 aligned with a cautious approach.

PRCT

Hold

Jul 06, 2026

Target

$25.00

Current

$19.30

Performance

-9.01%

Richard Newitter issued a Hold recommendation for PRCT on Jul 06, 2026, price target set at 25. Market action validated the conservative Hold outlook with shares at 19.3.

TNDM

Buy

May 11, 2026

Target

$31.00

Current

$16.87

Performance

14.22%

On May 11, 2026, TNDM was evaluated by Richard Newitter, who gave a Buy rating and target of 31. This case illustrates how a timely bullish rating can translate into tangible gains of 14.22%.

ZBH

Hold

Apr 29, 2026

Target

$92.00

Current

$95.36

Performance

19.10%

Richard Newitter rated ZBH as Hold on Apr 29, 2026, setting a price target of 92. Despite the Hold call, shares climbed 19.10% to 95.36, revealing unexpected momentum.

CARL

Buy

Apr 15, 2026

Target

$18.00

Current

$15.58

Performance

—

On Apr 15, 2026, CARL was given a Buy rating by Richard Newitter, with a target price of 18. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

PEN

Hold

Jan 16, 2026

Target

$374.00

Current

$317.60

Performance

-9.46%

PEN received a Hold rating from Richard Newitter on Jan 16, 2026, aiming for 374. The Hold stance proved prudent, with the market softening by 9.46%.

IART

Hold

Oct 15, 2025

Target

$15.00

Current

$15.22

Performance

6.96%

On Oct 15, 2025, Richard Newitter published a Hold outlook on IART, with a target of 15. The Hold call missed some of the bullish momentum as shares advanced toward 15.

TFX

Hold

Mar 03, 2025

Target

$149.00

Current

$124.52

Performance

-7.85%

Richard Newitter on Mar 03, 2025 assigned TFX a Hold rating, with a price target of 149. The call successfully avoided chasing as shares lost 7.85%.

NARI

Hold

Dec 18, 2024

Target

$63.00

Current

$79.97

Performance

45.32%

On Dec 18, 2024, Richard Newitter reaffirmed NARI with a Hold rating, targeting 63. Market strength beyond 79.97 went further than the conservative outlook suggested.

NVRO

Hold

Dec 18, 2024

Target

$4.70

Current

$5.84

Performance

56.15%

NVRO was rated Hold by Richard Newitter on Dec 18, 2024, with a price objective of 4.7. Despite caution, upside momentum rewarded risk-takers with gains to 5.84.

Frequency Asked Questions

Who is Richard Newitter?

Richard Newitter is an analyst from Truist Securities specializing in the Healthcare sector.

What is Richard Newitter's success rate?

Richard Newitter currently has a success rate of +92.31%.

How many ratings has Richard Newitter issued?

Richard Newitter has issued 123 stock ratings so far.

What is the average return of Richard Newitter's calls?

Their stock ratings have generated an average return of +14.19%.

What is Richard Newitter's ranking?

Richard Newitter is ranked #1519 out of 4779 analysts.

What types of ratings does Richard Newitter give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Richard Newitter?

You can follow Richard Newitter by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Richard Newitter?

Their latest rating was a Buy on BBNX issued on 2026-09-15.